Label mix-up spurs recall of accord blood pressure meds

Label mix-up spurs recall of accord blood pressure meds

(HealthDay)—One lot of high blood pressure medication is being recalled after a labeling mix-up, Accord Healthcare Inc. has announced.

The recall is for 100-count bottles of hydrochlorothiazide tablets USP, 12.5 mg, lot PW05264. One of the bottles in that lot was found to contain 100 tablets of spironolactone, a drug used to treat heart failure, cirrhosis of the liver, and other conditions.

Using spironolactone instead of hydrochlorothiazide could have life-threatening consequences for some patients, Accord said. To date, the company has not received any reports of patient harm associated with the recall.

The hydrochlorothiazide tablets are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side. Patients with Accord hydrochlorothiazide tablets that do not look like this, or those who are unsure, should check with their pharmacist or health care provider for confirmation, the company said. It also advised patients to contact their health care provider if they've had any problems that may be related to taking the recalled medication.

For more information about the recall, contact Accord by phone at 1-855-869-1081.


Explore further

FDA recalls heart medication valsartan, citing cancer concerns

More information: More Information

Copyright © 2018 HealthDay. All rights reserved.

Citation: Label mix-up spurs recall of accord blood pressure meds (2018, August 30) retrieved 18 October 2019 from https://medicalxpress.com/news/2018-08-mix-up-spurs-recall-accord-blood.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more